跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NEOPLATIN - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
NEOPLATIN
Approved
STANDARD
NEOPLATIN
Zee Laboratories Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7aa66846e9f3c5b4
Company
Zee Laboratories Limited
Type
Standard
Approval Details
Approval Id
7aa66846e9f3c5b4
Drug Approval Philippines Name
NEOPLATIN
Product Name
NEOPLATIN
Registration Number
DR-XY42670
Brand Name
NEOPLATIN
Generic Name
CISPLATIN
Dosage Form
Solution For Injection
Dosage Strength
1 mg/mL
Manufacturer
Zee Laboratories Limited
Importer
Eon Pharmatek, Inc.
Distributor
Eon Pharmatek, Inc.
Issuance Date
24 January 2024
Expiry Date
06 January 2029
Pharmacologic Category
ANTINEOPLASTIC
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7aa66846e9f3c5b4
Type
Standard
Back to Philippines FDA Approvals